Invention Grant
- Patent Title: Inhibitors of HCV NS5A
- Patent Title (中): HCV NS5A抑制剂
-
Application No.: US14364818Application Date: 2012-12-13
-
Publication No.: US09133170B2Publication Date: 2015-09-15
- Inventor: John A. Brinkman , Ramakanth Sarabu , Sung-Sau So
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Nutley
- Assignee: HOFFMANN-LA ROCHE INC.
- Current Assignee: HOFFMANN-LA ROCHE INC.
- Current Assignee Address: US NJ Nutley
- International Application: PCT/EP2012/075322 WO 20121213
- International Announcement: WO2013/087743 WO 20130620
- Main IPC: C07D233/64
- IPC: C07D233/64 ; C07D237/26 ; C07D403/14 ; C07D487/06 ; A61K31/55 ; C07D487/04 ; A61K31/551 ; A61K31/4178 ; A61K45/06 ; A61K38/21
Abstract:
The present invention provides compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US20150166514A1 INHIBITORS OF HCV NS5A Public/Granted day:2015-06-18
Information query
